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Abstract
Sputum smear microscopy is widely used for tuberculosis diagnosis and treatment monitoring. We evaluated the
correlation between smear microscopy and time to liquid culture positivity during early tuberculosis treatment. The study
included patients with smear-positive pulmonary tuberculosis hospitalized at a tuberculosis reference centre in Germany
between 01/2012 and 05/2013. Patient records were reviewed and clinical, radiological and microbiological data were
analysed. Sputum samples were collected before treatment initiation and weekly thereafter. A number of 310 sputum
samples from 30 patients were analysed. Time to liquid culture positivity inversely correlated with smear grade (Spearman’s
rho 20.439, p,0.001). There was a better correlation within the first two months vs. after two months of therapy (20.519
vs. 20.416) with a trend to a more rapid increase in time to positivity between baseline and week 2 in patients who culture-
converted within the first two months (5.9 days vs. 9.4 days, p = 0.3). In conclusion, the numbers of acid-fast bacilli in
sputum smears of patients with pulmonary tuberculosis and time to culture positivity for M. tuberculosis cultures from
sputum are correlated before and during tuberculosis treatment. A considerable proportion of patients with culture
conversion after two months of therapy continued to have detectable acid-fast bacilli on sputum smears.
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Introduction
Tuberculosis (TB) continues to be a leading cause of morbidity
and mortality and is currently the fourth most common cause of
death from communicable diseases worldwide [1]. According to
World Health Organization (WHO), it is estimated that 8.6
million new TB cases occurred in 2011 worldwide resulting in 1.3
million deaths [2]. Although there were major developments in
diagnostic methods in recent years with the introduction of
automated molecular assays, TB treatment response is still
evaluated using traditional microbiological techniques such as
smear microscopy and sputum culture. Time to liquid culture
positivity can be used as a measure of bacterial burden and has
been shown to have an excellent inverse correlation with the
number of colony forming units on solid media [3]. Similarly,
smear microscopy has been shown to reflect the extent of disease
with higher smear grades being associated with a more extensive
lung involvement and the presence of cavitary lesions [4]. Smear
microscopy provides rapid results, is inexpensive, easy to perform,
does not require complex laboratory equipment and is therefore
very suitable for low-resource settings. Cultures on the other hand
are more expensive and results are available late.
Our objective was to evaluate the correlation between sputum
smear microscopy and time to culture positivity during TB
treatment.
Methods
Study population and setting
Observational cohort study of patients hospitalized with
pulmonary TB at the Clinical Tuberculosis Center of the German
Center for Infection Research (DZIF), the Medical Clinic Borstel,
Germany. Patient records were reviewed and data on clinical,
radiological and bacteriological characteristics were collected on
all patients with pulmonary TB admitted between January 2012
and May 2013 with at least two positive sputum smear results were
further analysed. HIV testing was performed in all patients.
Patients received weight-based daily anti-TB therapy according to
drug susceptibility testing results and the medical staff observed
each drug administration. Patients were hospitalized until acid-fast
bacilli became undetectable on sputum smears, or in the case of
patients with multidrug-resistant TB, until culture conversion.
Sample collection and processing
Early-morning sputum specimens were collected before the
initiation of anti-TB therapy and weekly thereafter until sputum
smear and culture conversion. Samples were processed according
to standard bacteriological procedures. Briefly, sputum samples
were digested and decontaminated by adding equal volumes of
sputum and N-acetyl-L-cysteine – sodium hydroxide solution.
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After 20 minutes the mixture was neutralized with phosphate
buffered saline and centrifuged. The sediment obtained was
resuspended in 1 ml sterile phosphate buffer and used for smear
preparation and inoculation in culture [5]. Sputum smear grading
was assessed using the Ziehl-Neelsen staining method as shown in
Table 1 [6]. Liquid cultures were performed using the BACTEC
MGIT 960 system (Becton Dickinson, Sparks, MD). Time to
culture positivity was defined as the number of days between
sample inoculation and detection of mycobacterial growth. Drug
susceptibility testing was performed on all positive initial cultures.
Conversion was defined as change from positive to repeatedly
negative (three consecutive samples) sputum smear microscopy
and negative culture results (culture conversion). Patients were
considered to have a negative microscopy after sustained smear
conversion (three consecutive negative microscopy results). Spu-
tum smear conversion under effective treatment defines a time
point when the infectiousness of patients has become very low. In
Germany, patients with drug-susceptible TB are generally
discharged from the hospital when sputum smear conversion
occurs while on effective treatment, while patients with MDR-TB
are generally discharged upon culture conversion, to minimize the
risk of transmission of MDR-strains of M. tuberculosis in the
community [7].
Radiological findings
The extent of lung involvement was assessed by two trained
physicians using the radiological score described by Ralph et al.
[4], which takes into account the proportion of lung affected and
the presence of cavitation.
Statistical analysis
Data processing and analysis were performed using SPSS v17.0
(SPSS Inc., Chicago, IL, USA). Spearman’s correlation coefficient
was used to assess the strength of associations between continuous
and ordinal variables. The Mann-Whitney test was used for
comparisons between groups. GraphPad Prism (GraphPad Soft-
ware Inc. San Diego, CA) statistical software was used to design
the figures.
Ethical approval
The Ethical Board of the University of Lu¨beck was consulted
and it was decided that the anonymous retrospective data analysis
did not need ethical board approval. Informed consent was not
obtained. Patient data were anonymized and de-identified prior to
analysis.
Results
Of 54 patients diagnosed with TB during the study period, 30
had at least two positive sputum smear results and were included
in the final analysis. Patients had a median age of 47.5 years (IQR
39–60) and 23 (77%) were male. According to their country of
birth, 16 (53%) were born in Germany, whereas the rest were not
German-born. All patients were HIV-seronegative. Seventeen
(57%) of patients were smokers and 7 (23%) were alcohol abusers.
Diabetes mellitus had been diagnosed in 3 (10%) patients.
Microbiological characteristics
Drug susceptibility testing (DST) results were available in all
patients. Twenty-seven (87%) patients had pan-drug-susceptible
TB. One patient had extensively drug-resistant TB, while the
other two had isoniazid drug-resistance, one of them in
combination with streptomycin drug-resistance. A total of 310
sputum samples were analysed. At treatment initiation, median
time to culture positivity was 10.5 (IQR 7–13 days) and increased
gradually during the course of treatment. At the start of treatment
13 (50%) of patients had numerous AFB bacilli on microscopy
with smear grades of 3+ and 4+. Figure 1 shows the evolution of
smear grade during therapy.
There was a negative correlation between smear microscopy
and time to culture positivity during the course of treatment
(Spearman’s correlation coefficient 20.439, p,0.001). The
evolution of smear microscopy grade and time to culture positivity
during anti-TB treatment is shown in Figure 2.
Median time to sputum smear conversion was 60 days (range
20–210 days), while median time to culture conversion was 57
days (range 21–151 days). Fifteen (52%) and 16 (57%) patients
underwent smear and culture conversion during the first two
months of therapy. Culture conversion occurred between 95 days
before smear conversion to 24 days after smear conversion. Six
patients (22%) experienced first smear followed by culture
conversion, in 9 patients (33%) smear and culture conversion
were documented simultaneously from the same specimens, while
in 12 patients (45%) smear conversion occurred after culture
conversion with a median delay of 22 (range 7–95) days. However
in 5 patients (19%) there was a more important delay in smear
conversion, which exceeded 1 month. For 3 patients the
relationship between the two events could not be precisely
determined.
In patients who experienced smear conversion within the first 2
months, culture conversion also occurred in 11 (86%) patients
within 2 weeks, while in those who smear-converted after 2
months of therapy, cultures became negative within 14 days in
only 5 (36%) patients. There was a significant difference in the
Table 1. Quantitative assessment of sputum specimens using microscopy [6].
Result Number of acid-fast bacilli
Bright light technique with 100-fold objective magnification
negative 0 on smear (300 fields examined)
6 1–12 on smear (300 fields examined)
+ 4–10 in 100 fields (100 fields examined)
++ 1–10 in 10 fields (100 fields examined)
+++ 1–10 per field of vision (50 fields examined)
++++ .10 per field of vision (20 fields examined)
doi:10.1371/journal.pone.0106075.t001
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Figure 1. The evolution of smear microscopy grade during the first 8 weeks of tuberculosis treatment.
doi:10.1371/journal.pone.0106075.g001
Figure 2. Sputum smear grade and time to liquid culture positivity during tuberculosis therapy (mean values with 95% CI
computed using GraphPad Prism are shown). Smear grades are expressed according to the number of visible acid-fast bacilli (AFB) with 0 (no
detectable AFB on slide); 1 (1–9 AFB in 300 oil immersion fields), 2 (4–39 AFB in 100 fields), 3 (4–9 AFB in 10 fields), 4 (1–9 AFB per field), 5 ($10 AFB
per field).
doi:10.1371/journal.pone.0106075.g002
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delay between culture and smear conversions between patients
with a smear conversion before vs. after 2 months of therapy
(U= 19, p,0.001).
Patients with culture conversion within the first 2 months also
had a longer time to culture positivity (U= 23, p = 0.014) and
tended to have a lower smear grade at baseline (U= 43, p = 0.08).
There was a stronger inverse correlation between smear micros-
copy and time to culture positivity for patients who experienced
smear conversion within the first 2 months (Spearman’s rho=2
0.519, p,0.001) than for patients who had a delayed smear
conversion (Spearman’s rho =20.416, p,0.001). A non-signifi-
cant higher increase in the difference between time to positivity
measured at week 2 and the beginning of treatment was observed
in patients who underwent culture conversion before month 2
(U= 31.5, p = 0.3). The mean 11 (IQR 2–15) increase in the
number of days was 9.4 days in patients who smear converted vs.
5.9 days 4 (IQR 2–8) in patients who did not. Figure 3 shows the
occurrence of smear and culture conversion during treatment.
Radiological findings
Chest X-rays were available for assessment for 29 patients.
Cavitary lesions were present in 27 (93%) and 19 (66%) had
bilateral lung involvement. Median chest X-ray score was
66 points (IQR 52–77.5). The X-ray score did not correlate with
baseline smear grade (Spearman’s rho= 0.15, p = 0.473) or time to
culture positivity (Spearman’s rho= 0.284, p = 0.189) and was not
associated with sputum smear conversion at 2 months (U= 72,
p = 0.355). In the 5 patients who had a time delay between smear
and culture conversion longer than 1 month, higher X-ray scores
were observed, with a median of 72.5 points (IQR 62.5–83.8)
(p = 0.291).
Discussion
The study assessed the correlation between time to liquid
culture positivity and sputum smear grade during the early course
of TB therapy. For this purpose serial sputum samples from
patients with pulmonary TB were analysed at a clinical TB
reference centre in a country of low TB incidence.
Many TB patients come from low-resource settings where
laboratories rely on sputum microscopy for diagnosis and
treatment monitoring. Although great progress has been made
for the rapid diagnosis of TB using molecular techniques such as
the Xpert MTB/RIF and there have been extensive efforts of
implementing them at concessional prices in developing countries
[8], treatment monitoring using molecular assays is difficult due to
their inability to differentiate between dead and live bacteria [9].
In a study assessing the performance of Xpert MTB/RIF for
monitoring treatment response the test correlated well with
sputum smear and culture during therapy. However, after 8
weeks of treatment the proportion of positive Xpert MTB/RIF
results was twice that of positive liquid cultures (42 vs. 84%) and an
important difference between the two persisted during the
remainder of the patient follow-up showing the limitations of this
method for treatment monitoring [10].
Sputum culture conversion at 2 months is the only widely
accepted marker of sterilizing activity and efficacy and is used for
monitoring therapy in patients with pulmonary TB [11,12]. Liquid
culture has become routine microbiology practice and its
introduction has improved the sensitivity for detection and
reduced the time to result by more than a week in comparison
to conventional culture on Lo¨wenstein-Jensen medium [13].
Additionally, liquid culture has a considerably higher sensitivity
than smear microscopy. While the limit of detection for culture in
liquid media is 10–50 colony forming units/ml, samples must
contain about 10,000 colony forming units/ml to be positive on
smear microscopy [14]. Nevertheless liquid culture can require
more days to weeks until the results are available and therefore
cannot be used for rapid decision-making concerning TB-therapy.
Time to culture positivity has been shown to correlate to bacterial
load as assessed by the number of colony forming units on solid
media, and gradually increases during the course of anti-TB
treatment [3].
Bactericidal activity studies have shown that bacterial killing
does not follow a linear trend. After treatment start there is an
Figure 3. Sputum smear conversion and liquid culture conversion during tuberculosis therapy.
doi:10.1371/journal.pone.0106075.g003
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initial rapid reduction in the sputum bacterial load that can lead to
a 20-fold reduction in the number of colony forming units during
the first two days of therapy followed by a further reduction of
200-fold over the next 12 days [15,16].
In this study a trend to a more rapid increase in time to
positivity between baseline and 2 weeks after treatment initiation
was observed in patients who underwent culture conversion at 2
months vs. patients who did not. Therefore this measure could
possibly be used to identify patients with a better response to
therapy. It should be evaluated, whether these patients can benefit
from a shorter duration of treatment without an increased risk for
relapse. Other authors also found that the rate of increase in time
to positivity can predict 2-month smear conversion and thus
identify patients with a better overall treatment response [17].
Interestingly, using 2-months sputum smear conversion we
could identify two subgroups of patients with different responses to
therapy. Patients from the first subgroup underwent smear and
culture conversion within the first two months and had a relatively
small delay between these two events, whereas patients whose
sputum cultures became negative after two months of therapy had
more often a longer delay before the occurrence of smear
conversion. In another study of patients with smear positive
pulmonary TB, it was also noted that up to a third of patients had
detectable acid-fast bacilli on sputum smear microscopy and
negative M. tuberculosis cultures after 2 months of treatment [18].
However, this did not lead to an increased mortality or relapse risk
in this patient subgroup [18]. Similarly, persistently positive
microscopy results are more likely to be associated with negative
cultures, but not with treatment failure and more than 5% of
patients have this pattern after 20 weeks of therapy [19]. It has
been suggested that this pattern of smear positive, culture negative
could be related to rifampicin use, older age and the extent of
disease [18,20]. Persistently positive sputum smears might cause
concern and lead to changes in patient management and isolation
practices, however this pattern is not uncommon and should not
prompt changes in therapy in the absence of signs of disease
progression [18]. It has also been shown that about 2% of patients
might be smear positive - culture negative at treatment completion
and this could be due to non-viable bacteria and colonization by
non-tuberculous mycobacteria [21].
In this study, two thirds of patients who underwent culture
conversion after 2 months, had AFB present on smear microscopy
for more than 2 weeks after cultures had become negative.
Although there is a good overall correlation between smear
microscopy and time to culture positivity during the first 2 months,
the strength of the correlation appears to decrease after 2 months
in individual cases. This might be due to the presence of a higher
proportion of non-culturable bacteria after this period and suggests
that smear grade might be a better predictor of culturable bacteria
within the first 2 months of treatment. Other authors have shown
that as the smear grade decreases during treatment, the proportion
of negative cultures among smear positive patients increases
suggesting a rise in the proportion of non-culturable bacteria in the
sample [22].
The fact that there are patients who no longer have culturable
bacteria in sputum and therefore are likely non-contagious but
who continue to have AFB on microscopy stresses the importance
of developing new methods that could rapidly and accurately
identify this subgroup. A method that might be useful in
differentiating between viable and killed mycobacteria is the
fluorescein diacetate vital staining. In this method intracellular
accumulation of fluorescein occurs in cells with preserved
membrane integrity marking cell viability [23]. Fluorescein
diacetate vital staining has been used in patients with delayed
smear conversion to identify cases of treatment failure earlier [24].
In contrast to sputum smear microscopy and molecular methods
culture results are not immediately available. This has an
importance because this leads to prolonged hospitalization and
therefore increased costs and exposes patients to the risk of
infection with drug-resistant TB strains. This underlines the
importance of the search for biological markers that are better
associated with bacterial killing and sterilizing activity of anti-TB
drugs that could be used for monitoring patients under therapy.
The study included only three patients with drug-resistant TB
reflecting the low proportion of resistance in the population.
Radiological extent of TB disease evaluated using the propor-
tion of affected lung and the presence of cavities has been shown to
be associated to a higher baseline smear grade and can predict
smear conversion at 2 months [4]. In this study however
radiological score was not associated with smear conversion,
possibly due to the small sample size.
This study is limited by the relative small sample size,
nevertheless it provides an interesting view on the correlation
between the two most important tests used for treatment
monitoring of patients with pulmonary tuberculosis and it shows
that smear microscopy could provide a rough estimate of the fall in
sputum bacterial load particularly during the first two months of
therapy. Another limitation of this study is the use of a
decontamination procedure of the sputum samples which leads
to killing of a fraction of the mycobacteria present. However this a
standardized procedure laboratories employed by many laborato-
ries.
In conclusion, there is a strong correlation between time to
culture positivity and smear microscopy grade during treatment in
patients with pulmonary TB. This finding might be of use to
clinicians from resource-limited settings where cultures are difficult
to perform or unavailable by supporting the use of smear
microscopy in estimating the dynamics of bacterial load during
treatment. Two subgroups of patients can be identified: one with
conversion within the first two months who had a stronger
correlation between time to culture positivity and smear grade and
a second group who underwent conversion after two months in
whom a greater delay between the two events was present.
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